ES2106852T3 - Composicion oftalmica que contiene hemihidrato de timolol. - Google Patents

Composicion oftalmica que contiene hemihidrato de timolol.

Info

Publication number
ES2106852T3
ES2106852T3 ES92850297T ES92850297T ES2106852T3 ES 2106852 T3 ES2106852 T3 ES 2106852T3 ES 92850297 T ES92850297 T ES 92850297T ES 92850297 T ES92850297 T ES 92850297T ES 2106852 T3 ES2106852 T3 ES 2106852T3
Authority
ES
Spain
Prior art keywords
compsn
adjusters
pref
composition containing
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92850297T
Other languages
English (en)
Inventor
Markku Peralampi
Kari Lehmussaari
Olli Oksala
Esko Pohjala
Timo Reunamaki
Jarkko Ruohonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Oy
Original Assignee
Santen Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Oy filed Critical Santen Oy
Application granted granted Critical
Publication of ES2106852T3 publication Critical patent/ES2106852T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICIONES QUE CONTIENEN S (3-TEXT-BUTILAMINO-2HIDROXIPROPOXI) DRATADO UTIL PARA LA ADMINISTRACION A UN PACIENTE, PARTICULARMENTE PARA ADMINISTRACION TOPICA COMO UN AGENTE FARMACEUTICO PARA EL TRATAMIENTO DE UN GLAUCOMA O HIPERTENSION OCULAR.
ES92850297T 1992-07-08 1992-12-16 Composicion oftalmica que contiene hemihidrato de timolol. Expired - Lifetime ES2106852T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91066592A 1992-07-08 1992-07-08

Publications (1)

Publication Number Publication Date
ES2106852T3 true ES2106852T3 (es) 1997-11-16

Family

ID=25429138

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92850297T Expired - Lifetime ES2106852T3 (es) 1992-07-08 1992-12-16 Composicion oftalmica que contiene hemihidrato de timolol.

Country Status (21)

Country Link
EP (1) EP0577913B1 (es)
JP (1) JP3094233B2 (es)
KR (1) KR100278851B1 (es)
AT (1) ATE154513T1 (es)
AU (1) AU678972B2 (es)
BR (1) BR9306800A (es)
CA (1) CA2139781C (es)
CZ (1) CZ282168B6 (es)
DE (1) DE69220484T2 (es)
DK (1) DK0577913T3 (es)
EE (1) EE03078B1 (es)
ES (1) ES2106852T3 (es)
FI (1) FI112321B (es)
GR (1) GR3024648T3 (es)
HK (1) HK1007503A1 (es)
HU (1) HU221618B1 (es)
NO (1) NO306535B1 (es)
NZ (1) NZ253164A (es)
PL (1) PL172503B1 (es)
SG (1) SG49770A1 (es)
WO (1) WO1994001115A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0968716B1 (en) * 1996-10-28 2008-12-31 Senju Pharmaceutical Co., Ltd. Drugs for ameliorating ocular circulatory disorders
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
WO2004098592A1 (ja) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. オキサゾリジノン誘導体含有組成物
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
JP2014024794A (ja) * 2012-07-27 2014-02-06 Nippon Tenganyaku Kenkyusho:Kk チモロールまたはその薬学的に許容される塩を含有する水性組成物およびその光安定化方法
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195085A (en) 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
FI82240C (fi) 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.

Also Published As

Publication number Publication date
EP0577913B1 (en) 1997-06-18
KR950702422A (ko) 1995-07-29
HU221618B1 (hu) 2002-12-28
HU9500035D0 (en) 1995-03-28
EP0577913A1 (en) 1994-01-12
NO306535B1 (no) 1999-11-22
FI950050A (fi) 1995-01-04
HUT72657A (en) 1996-05-28
NO950059L (no) 1995-01-06
JPH07508745A (ja) 1995-09-28
PL307051A1 (en) 1995-05-02
HK1007503A1 (en) 1999-04-16
KR100278851B1 (ko) 2001-01-15
AU4329693A (en) 1994-01-31
CA2139781C (en) 2003-09-23
JP3094233B2 (ja) 2000-10-03
WO1994001115A1 (en) 1994-01-20
GR3024648T3 (en) 1997-12-31
NZ253164A (en) 1996-01-26
DK0577913T3 (da) 1998-01-26
CZ4495A3 (en) 1995-09-13
ATE154513T1 (de) 1997-07-15
EE03078B1 (et) 1998-04-15
PL172503B1 (pl) 1997-10-31
SG49770A1 (en) 1998-06-15
NO950059D0 (no) 1995-01-06
AU678972B2 (en) 1997-06-19
FI950050A0 (fi) 1995-01-04
FI112321B (fi) 2003-11-28
CZ282168B6 (cs) 1997-05-14
BR9306800A (pt) 1998-12-08
CA2139781A1 (en) 1994-01-20
DE69220484T2 (de) 1998-02-05
DE69220484D1 (de) 1997-07-24

Similar Documents

Publication Publication Date Title
ATE151640T1 (de) Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel
ES2184836T3 (es) Composiciones que contienen derivados de azol para aplicacion topica en la piel.
MX173433B (es) Composicion acuosa de ibuprofen y procedimiento para su preparacion
ES2098672T3 (es) Composiciones farmaceuticas estabilizadas que contienen derivados de vitaminas d2 y d3.
MX168660B (es) Composiciones hipotonicas acuosas para lentes de contacto
PT101061A (pt) Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais
ES2100560T3 (es) Formulaciones cosmeticas y dermatologicas de proteccion solar que contienen tioles y/o derivados de tiol.
KR970703746A (ko) 육모제(hair growth stimulant)
KR870006891A (ko) 구강 위생 조성물
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.
CO4930267A1 (es) Composiciones que contienen cisteina de n acetilo utiles en el tratamiento de heridas cronicas
ES2106852T3 (es) Composicion oftalmica que contiene hemihidrato de timolol.
ES2113358T3 (es) Composiciones antidiarreicas.
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
FI961336A (fi) Menetelmä silmänesteiden säilömiseksi ja koostumuksia tätä varten
KR940006575A (ko) 증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
AR002281A1 (es) Compuesto antimigrana derivado del 1,2,5-tiadiazol de las indolilalquil- piridinil y pirimidinil-piperazina, composicion farmaceutica que lo contiene
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
JPS5714517A (en) Whitening cosmetic
ATE270114T1 (de) Zusammensetzungen und gegenstände zur verminderung der auswirkung von entzündungen
DK0420798T3 (da) Antimikrobielle præparater
KR880011161A (ko) Ll-f 28249 화합물의 모노-및 디에폭시드 유도체와 그의 사용방법 및 그 유도체를 포함하는 조성물
IE800344L (en) Anti-perspirant compositions
ES2196910T3 (es) Composiciones de aciclovir que contienen dimeticona.
DE69902925T2 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 577913

Country of ref document: ES